Literature DB >> 15784374

Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?

Christophe Doddoli1, Adrian Aragon, Fabrice Barlesi, Bruno Chetaille, Stéphane Robitail, Roger Giudicelli, Pierre Fuentes, Pascal Thomas.   

Abstract

OBJECTIVE: To assess the therapeutic effect of the extent of lymph node dissection performed in patients with a stage pI non-small-cell lung cancer (NSCLC).
METHODS: We analysed data on 465 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. The median number of lymph node sampled was 10 and the median number of ipsilateral mediastinal lymph node stations sampled was two. We chose to define a procedure that harvested 10 or more lymph nodes and sampled two or more ipsilateral mediastinal stations as a lymphadenectomy, by contrast with sampling when one or both criteria were not satisfied. The effect of the surgical techniques: lymph node sampling (LS; n=207) vs. lymphadenectomy (LA; n=258) on 30-day mortality and overall survival were investigated.
RESULTS: A total of 6244 lymph nodes was examined, including 4306 mediastinal lymph nodes. The mean (+/-SD) numbers of removed lymph nodes were 7+/-6.1 per patient following LS vs.18.6+/-9.3 following LA (P=0.001). An average mean of 1+/-0.90 mediastinal lymph node station per patient was sampled following LS vs. 2.7+/-0.8 following LA (P<10(-6)). Overall 30-day mortality rates were 2.4 and 3.1%, respectively. LA was disclosed as a favourable prognosticator at multivariate analysis (Hazard Risk: 1.43; 95% Confidence Interval: 1.00-2.04; P=0.048), together with younger patient age, absence of blood vessels invasion, and smaller tumour size.
CONCLUSIONS: Importance of lymph node dissection affects patients outcome, while it does not enhance the operative mortality. A minimum of 10 lymph nodes assessed, and two mediastinal stations sampled are suggested as possible pragmatic markers of the quality of lymphadenectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15784374     DOI: 10.1016/j.ejcts.2004.12.035

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  48 in total

1.  The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer.

Authors:  Mark W Hennon; Luke H DeGraaff; Adrienne Groman; Todd L Demmy; Sai Yendamuri
Journal:  Eur J Cardiothorac Surg       Date:  2020-05-01       Impact factor: 4.191

2.  Efficacy of mediastinal lymph node dissection during thoracoscopic lobectomy.

Authors:  Hanghang Wang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2012-05

3.  Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Samuel Hawkins; Olya Stringfield; Matthew B Schabath; Qian Li; Fangyuan Qu; Shichang Liu; Alberto L Garcia; Zhaoxiang Ye; Robert J Gillies
Journal:  Med Phys       Date:  2018-04-29       Impact factor: 4.071

4.  Prognostic factors for surgically managed patients with stage II non-small cell lung cancer.

Authors:  Liming Wang; Yang Liu; Shun Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Improved lymph node staging in early-stage lung cancer in the national cancer database: commentary.

Authors:  Hisashi Saji; Koji Kojima; Haruhiko Nakamura
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.

Authors:  Brian C Gulack; Chi-Fu Jeffrey Yang; Paul J Speicher; James M Meza; Lin Gu; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; Mark F Berry
Journal:  Lung Cancer       Date:  2015-10-14       Impact factor: 5.705

7.  Does an extended mediastinal lymphadenectomy improve outcome after R0 resection in lung cancer?

Authors:  Nan Wu; Shi Yan; Chao Lv; Shaolei Li; Yuan Feng; Yuzhao Wang; Jia Wang; Qingfeng Zheng; Yue Yang
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

Review 8.  Systematic mediastinal lymphadenectomy or mediastinal lymph node sampling in patients with pathological stage I NSCLC: a meta-analysis.

Authors:  Siyuan Dong; Jiang Du; Wenya Li; Shuguang Zhang; Xinwen Zhong; Lin Zhang
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

9.  The necessity of mediastinal lymph node resection for screen-diagnosed non-small cell lung cancer (NSCLC) manifesting as subsolid nodule.

Authors:  Sukki Cho
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

10.  Intraoperative frozen sections of the regional lymph nodes contribute to surgical decision-making in non-small cell lung cancer patients.

Authors:  Wei Li; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Song Dong; Hao-Ran Zhai; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.